Novel approaches to support therapeutic development in ultra-rare cancers
OpenUpdated: Oct 30, 2025
Summary
The purpose of this grant is to explore novel approaches for therapeutic development in ultra-rare cancers. Eligible applicants include private and public institutions of higher education, nonprofit organizations, government entities, and for-profit businesses, including small businesses. To apply or for more information, interested parties should contact the FDA via email at patrick.johnson@fda.hhs.gov.
Full Description
Description
This funding opportunity aims to explore the use of novel approaches to facilitate therapeutic development in ultra-rare cancers.
Eligibility
Eligible applicants
Education
- Private institutions of higher education
- Independent school districts
- Public and state institutions of higher education
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
Government
- Federally recognized Native American tribal governments
- Public and Indian housing authorities
- State governments
- County governments
- City or township governments
- Special district governments
Business
- For-profit organizations other than small businesses
- Small businesses
Additional information
Grantor contact information
Description
Contact FDA About this Opportunity
Recommended Resource
Grant Writing Services on Fiverr
Top PickStruggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.